Related Experiment Video

Updated: Aug 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs

B Belletti1, M S Nicoloso, M Schiappacassi

  • 1Division of Experimental Oncology, Centro di Riferimento Oncologico, Via Pedemontana occidentale, 12, Aviano 33081, Italy.

Current Medicinal Chemistry
|July 19, 2005
PubMed

Insights

The cell cycle regulator p27(kip1) is crucial for preventing cancer. Its inactivation, through degradation or functional impairment, is linked to poor prognosis and reduced survival in human cancers.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The cell cycle is a tightly regulated process essential for cell division.
  • Cyclin-dependent kinases (CDKs) drive cell cycle progression.
  • CDK inhibitors (CKIs) counteract CDK activity, ensuring proper cell cycle timing.

Purpose of the Study:

  • To review the role of the CKI p27(kip1) in human cancer.
  • To focus on mechanisms of p27(kip1) functional inactivation in tumor cells.
  • To discuss therapeutic strategies targeting p27(kip1).

Main Methods:

  • Review of existing literature on p27(kip1) in cancer.
  • Analysis of mechanisms of p27(kip1) downregulation (degradation and functional inactivation).
  • Discussion of clinical implications and therapeutic approaches.

Main Results:

  • p27(kip1) downregulation is often achieved by proteasomal degradation.
  • Reduced p27(kip1) levels correlate with worse prognosis and reduced survival in various human cancers.
  • Functional inactivation of p27(kip1), distinct from degradation, is also proposed.

Conclusions:

  • Deregulation of p27(kip1) (degradation or functional inactivation) contributes to cancer progression.
  • Understanding these mechanisms is vital for developing targeted cancer therapies.
  • Therapeutic strategies aimed at restoring p27(kip1) function hold promise.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...